Elevance Health, Inc. - stock earnings
ELV Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| July 17, 2024 BeforeMarket | 42.4 billion | 43.1 billion | 43.8 billion |
ELV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 2.2 billion USD | 42.6 billion USD |
| 2023Q4 | 856.0 million USD | 42.6 billion USD |
| 2023Q3 | 1.3 billion USD | 42.8 billion USD |
| 2023Q2 | 1.9 billion USD | 43.7 billion USD |
| 2023Q1 | 2.0 billion USD | 42.2 billion USD |
| 2022Q4 | 977.0 million USD | 39.0 billion USD |
| 2022Q3 | 1.6 billion USD | 39.9 billion USD |
| 2022Q2 | 1.7 billion USD | 38.6 billion USD |
| 2022Q1 | 1.8 billion USD | 38.1 billion USD |
| 2021Q4 | 1.1 billion USD | 34.9 billion USD |
| 2021Q3 | 1.5 billion USD | 35.8 billion USD |
| 2021Q2 | 1.8 billion USD | 33.9 billion USD |
| 2021Q1 | 1.7 billion USD | 32.4 billion USD |
| 2020Q4 | 551.0 million USD | 31.8 billion USD |
| 2020Q3 | 222.0 million USD | 31.2 billion USD |
| 2020Q2 | 2.3 billion USD | 29.3 billion USD |
| 2020Q1 | 1.5 billion USD | 29.6 billion USD |
| 2019Q4 | 934.0 million USD | 27.4 billion USD |
| 2019Q3 | 1.2 billion USD | 26.7 billion USD |
| 2019Q2 | 1.1 billion USD | 25.5 billion USD |
| 2019Q1 | 1.6 billion USD | 24.7 billion USD |
| 2018Q4 | 425.0 million USD | 23.4 billion USD |
| 2018Q3 | 960.0 million USD | 23.3 billion USD |
| 2018Q2 | 1.1 billion USD | 22.9 billion USD |
| 2018Q1 | 1.3 billion USD | 22.5 billion USD |
| 2017Q4 | 1.2 billion USD | 22.7 billion USD |
| 2017Q3 | 746.9 million USD | 22.4 billion USD |
| 2017Q2 | 855.3 million USD | 22.4 billion USD |
| 2017Q1 | 1.0 billion USD | 22.5 billion USD |
| 2016Q4 | 368.4 million USD | 21.7 billion USD |
| 2016Q3 | 617.8 million USD | 21.4 billion USD |
| 2016Q2 | 780.6 million USD | 21.5 billion USD |
| 2016Q1 | 703.0 million USD | 20.3 billion USD |
| 2015Q4 | 180.9 million USD | 20.2 billion USD |
| 2015Q3 | 654.8 million USD | 19.9 billion USD |
| 2015Q2 | 859.1 million USD | 20.0 billion USD |
| 2015Q1 | 865.2 million USD | 19.1 billion USD |
| 2014Q4 | 506.7 million USD | 19.0 billion USD |
| 2014Q3 | 630.9 million USD | 18.6 billion USD |
| 2014Q2 | 731.1 million USD | 18.5 billion USD |
| 2014Q1 | 701.0 million USD | 17.9 billion USD |
| 2013Q4 | 148.2 million USD | 17.6 billion USD |
| 2013Q3 | 656.2 million USD | 18.0 billion USD |
| 2013Q2 | 800.1 million USD | 17.8 billion USD |
| 2013Q1 | 885.2 million USD | 17.7 billion USD |
| 2012Q4 | 464.2 million USD | 15.5 billion USD |
| 2012Q3 | 691.2 million USD | 15.4 billion USD |
| 2012Q2 | 643.6 million USD | 15.4 billion USD |
| 2012Q1 | 856.5 million USD | 15.4 billion USD |
| 2011Q4 | 335.3 million USD | 15.3 billion USD |
| 2011Q3 | 683.2 million USD | 15.4 billion USD |
| 2011Q2 | 701.6 million USD | 15.1 billion USD |
| 2011Q1 | 926.6 million USD | 14.9 billion USD |
| 2010Q4 | 548.8 million USD | 14.6 billion USD |
| 2010Q3 | 739.1 million USD | 14.6 billion USD |
| 2010Q2 | 722.4 million USD | 14.5 billion USD |
| 2010Q1 | 876.8 million USD | 15.1 billion USD |
| 2009Q4 | 2.7 billion USD | 19.0 billion USD |
| 2009Q3 | 730.2 million USD | 15.4 billion USD |
| 2009Q2 | 693.5 million USD | 15.4 billion USD |
| 2009Q1 | 580.4 million USD | 15.1 billion USD |
| 2008Q4 | 331.4 million USD | 15.1 billion USD |
| 2008Q3 | 820.7 million USD | 15.0 billion USD |
| 2008Q2 | 750.5 million USD | 15.7 billion USD |
| 2008Q1 | 588.1 million USD | 15.6 billion USD |
| 2007Q4 | 859.1 million USD | 15.6 billion USD |
| 2007Q3 | 868.0 million USD | 15.2 billion USD |
| 2007Q2 | 835.2 million USD | 15.3 billion USD |
| 2007Q1 | 783.1 million USD | 15.1 billion USD |
| 2006Q4 | 801.1 million USD | 14.6 billion USD |
| 2006Q3 | 810.8 million USD | 14.4 billion USD |
| 2006Q2 | 751.2 million USD | 14.2 billion USD |
| 2006Q1 | 731.8 million USD | 13.8 billion USD |
| 2005Q4 | 652.0 million USD | 11.4 billion USD |
| 2005Q3 | 640.7 million USD | 11.3 billion USD |
| 2005Q2 | 559.4 million USD | 11.3 billion USD |
| 2005Q1 | 611.7 million USD | 11.1 billion USD |
| 2004Q4 | 184.5 million USD | 6.8 billion USD |
| 2004Q3 | 242.1 million USD | 4.8 billion USD |
| 2004Q2 | 237.9 million USD | 4.6 billion USD |
| 2004Q1 | 295.6 million USD | 4.6 billion USD |
| 2003Q4 | 208.8 million USD | 4.3 billion USD |
| 2003Q3 | 196.5 million USD | 4.3 billion USD |
| 2003Q2 | 177.3 million USD | 4.1 billion USD |
| 2003Q1 | 191.7 million USD | 4.1 billion USD |
| 2002Q4 | 171.9 million USD | 4.0 billion USD |
| 2002Q3 | 171.2 million USD | 3.6 billion USD |
| 2002Q2 | 106.2 million USD | 2.9 billion USD |
| 2002Q1 | 99.8 million USD | 2.8 billion USD |
| 2001Q4 | 87.7 million USD | 2.7 billion USD |
| 2001Q3 | 111.5 million USD | 2.7 billion USD |
| 2001Q2 | 72.4 million USD | 2.5 billion USD |
| 2001Q1 | 70.6 million USD | 2.6 billion USD |
| 2000Q4 | 72.2 million USD | 2.4 billion USD |
| 2000Q3 | 63.5 million USD | 2.3 billion USD |
| 2000Q2 | 49.9 million USD | 2.1 billion USD |
| 2000Q1 | 40.4 million USD | 2.0 billion USD |
ELV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.0 billion USD | 171.3 billion USD |
| 2022 | 5.9 billion USD | 156.6 billion USD |
| 2021 | 6.2 billion USD | 138.6 billion USD |
| 2020 | 4.6 billion USD | 121.9 billion USD |
| 2019 | 4.8 billion USD | 104.2 billion USD |
| 2018 | 3.8 billion USD | 92.1 billion USD |
| 2017 | 3.8 billion USD | 90.0 billion USD |
| 2016 | 2.5 billion USD | 84.9 billion USD |
| 2015 | 2.6 billion USD | 79.2 billion USD |
| 2014 | 2.6 billion USD | 73.9 billion USD |
| 2013 | 2.5 billion USD | 71.0 billion USD |
| 2012 | 2.7 billion USD | 61.7 billion USD |
| 2011 | 2.6 billion USD | 60.7 billion USD |
| 2010 | 2.9 billion USD | 58.8 billion USD |
| 2009 | 4.7 billion USD | 65.0 billion USD |
| 2008 | 2.5 billion USD | 61.3 billion USD |
| 2007 | 3.3 billion USD | 61.1 billion USD |
| 2006 | 3.1 billion USD | 57.0 billion USD |
| 2005 | 2.5 billion USD | 45.1 billion USD |
| 2004 | 960.1 million USD | 20.8 billion USD |
| 2003 | 774.3 million USD | 16.8 billion USD |
| 2002 | 549.1 million USD | 13.3 billion USD |
| 2001 | 342.2 million USD | 10.4 billion USD |
| 2000 | 226.0 million USD | 17.3 billion USD |
| 1999 | 44.9 million USD | 12.4 billion USD |
| 1998 | 172.4 million USD | 11.1 billion USD |
ELV
List: Contenders
Price: $533.73
52 week price:
Dividend Yield: 1.23%
5-year range yield:
Forward Dividend Yield: 1.23%
Payout Ratio: 25.86%
Payout Ratio Range:
Dividend Per Share: 6.52 USD
Earnings Per Share: 25.22 USD
P/E Ratio: 20.04
Exchange: NYQ
Sector: Healthcare
Industry: Healthcare Plans
Volume: 1.2 million
Market Capitalization: 123.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 16.69%
DGR5: 13.77%
DGR10: 16.01%